Back
Mersana Therapeutics Stock Price Chart

The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Sell
29
MRSN
Mersana Therapeutics
Last Price:
$0.37
Seasonality Move:
-12.2%
7 Day Trial
ALL ACCESS PASS
$
7

Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
The current trend is relatively stagnant and MRSN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Mersana Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.36 | Buy |
20-day SMA: | 0.36 | Buy |
50-day SMA: | 0.35 | Buy |
200-day SMA: | 1.19 | Sell |
8-day EMA: | 0.36 | Buy |
20-day EMA: | 0.36 | Buy |
50-day EMA: | 0.41 | Sell |
200-day EMA: | 1.11 | Sell |
Mersana Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.02 | Buy |
Chaikin Money Flow: | 1220703 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.33 - 0.39) | Buy |
Bollinger Bands (100): | (0.31 - 0.65) | Sell |
Mersana Therapeutics Technical Analysis
May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.37 while MRSN 8-day simple moving average is 0.36, which is a Buy signal.
-
The stock price of MRSN is 0.37 while Mersana Therapeutics 20-day SMA is 0.36, which makes it a Buy.
-
Mersana Therapeutics 50-day simple moving average is 0.35 while MRSN share price is 0.37, making it a Buy technically.
-
MRSN stock price is 0.37 and Mersana Therapeutics 200-day simple moving average is 1.19, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
29
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a SellThe current Mersana Therapeutics [MRSN] share price is $0.37. The Score for MRSN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
46M
Price in USD:
0.37
Share Volume:
1.2M
Mersana Therapeutics 52-Week Range
52-Week High:
2.83
52-Week Low:
0.26
Sell
29
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?The Mersana Therapeutics stock price is 0.37 USD today.
-
Will MRSN stock go up or go down?Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mersana Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.37 while MRSN 8-day exponential moving average is 0.36, which is a Buy signal.
-
The stock price of MRSN is 0.37 while Mersana Therapeutics 20-day EMA is 0.36, which makes it a Buy.
-
Mersana Therapeutics 50-day exponential moving average is 0.41 while MRSN share price is 0.37, making it a Sell technically.
-
MRSN stock price is 0.37 and Mersana Therapeutics 200-day simple moving average is 1.11, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.01 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
-
MRSN Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Mersana Therapeutics is a Sell
-
Mersana Therapeutics Relative Strength Index (RSI) is 51.02, which suggest Mersana Therapeutics is overbought
-
The Bollinger Bands (25) for Mersana Therapeutics is (0.33 - 0.39), which suggest Mersana Therapeutics is a Sell
-
The Bollinger Bands (100) for Mersana Therapeutics is (0.31 - 0.65), which suggest Mersana Therapeutics is a Sell
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.